Literature DB >> 8877404

Effects of macrophage colony-stimulating factor (M-CSF) on lipopolysaccharide (LPS)-induced mediator production from monocytes in vitro.

E Asakura1, T Hanamura, A Umemura, K Yada, T Yamauchi, T Tanabe.   

Abstract

M-CSF is a macrophage-lineage-specific growth factor that causes proliferation and differentiation of progenitor cells in the bone marrow. To investigate the effects of M-CSF on more matured cells, human monocytes were cultured in the presence or absence of M-CSF for 6 days. Addition of M-CSF at more than 10(2) U/ml resulted in higher viability and caused morphological differentiation to large macrophage-like cells. LPS-induced mediator production was also compared between M-CSF-treated and control cell. Monocytes were incubated with or without M-CSF for 3 days, and were stimulated with 1 microgram/ml of LPS for 2 days. IL-1 beta was not detected in the both culture supernatants, and PGE2 production was not influenced by M-CSF. However, amounts of G-CSF, GM-CSF, IL-6, and TNF-alpha produced in response to 1 microgram/ml of LPS were 1.5 to 2 times greater from monocytes treated with 10(4) U/ml of M-CSF than from control cells. The priming effect of M-CSF on LPS-induced cytokine production was found to require 3-day preincubation, and reached a maximum at the concentration of 10(4) U/ml. M-CSF-treated cells responded to a 10 times lower concentration of LPS than control cells in terms of cytokine production. M-CSF was also shown by flowcytometric analysis to influence the expression of CD14, a receptor for LPS, which might render monocytes more sensitive to LPS.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8877404     DOI: 10.1016/S0171-2985(96)80047-7

Source DB:  PubMed          Journal:  Immunobiology        ISSN: 0171-2985            Impact factor:   3.144


  8 in total

1.  HIV-1 does not alter in vitro and in vivo IL-10 production by human monocytes and macrophages.

Authors:  A Bergamini; F Bolacchi; E Faggioli; R Placido; S Vendetti; L Cappannoli; L Ventura; G Cerasari; I Uccella; M Andreoni; G Rocchi
Journal:  Clin Exp Immunol       Date:  1998-04       Impact factor: 4.330

2.  CSF1 overexpression has pleiotropic effects on microglia in vivo.

Authors:  Ishani De; Maria Nikodemova; Megan D Steffen; Emily Sokn; Vilena I Maklakova; Jyoti J Watters; Lara S Collier
Journal:  Glia       Date:  2014-07-05       Impact factor: 7.452

3.  Granulocyte-macrophage colony-stimulating factor amplification of interleukin-1beta and tumor necrosis factor alpha production in THP-1 human monocytic cells stimulated with lipopolysaccharide of oral microorganisms.

Authors:  A A Baqui; T F Meiller; J J Chon; B F Turng; W A Falkler
Journal:  Clin Diagn Lab Immunol       Date:  1998-05

4.  Monocyte proliferation induced by modified serum is associated with endogenous M-CSF production: evidence for involvement of a signalling pathway via scavenger receptors.

Authors:  E Asakura; N Tojo; T Tanabe
Journal:  Cell Prolif       Date:  1999-08       Impact factor: 6.831

5.  Granulocyte-macrophage colony-stimulating factor regulates cytokine production in cultured macrophages through CD14-dependent and -independent mechanisms.

Authors:  A Bergamini; F Bolacchi; B Bongiovanni; M Cepparulo; L Ventura; M Capozzi; C Sarrecchia; G Rocchi
Journal:  Immunology       Date:  2000-10       Impact factor: 7.397

6.  hLMSC Secretome Affects Macrophage Activity Differentially Depending on Lung-Mimetic Environments.

Authors:  Bryan Falcones; Zackarias Söderlund; Arturo Ibáñez-Fonseca; Isaac Almendros; Jordi Otero; Ramon Farré; Sara Rolandsson Enes; Linda Elowsson Rendin; Gunilla Westergren-Thorsson
Journal:  Cells       Date:  2022-06-08       Impact factor: 7.666

Review 7.  Is There a Role for Hematopoietic Growth Factors During Sepsis?

Authors:  Benjamin G Chousterman; Marine Arnaud
Journal:  Front Immunol       Date:  2018-06-21       Impact factor: 7.561

8.  Intravenous delivery of granulocyte-macrophage colony stimulating factor impairs survival in lipopolysaccharide-induced sepsis.

Authors:  Jörg Krebs; Alexander Hillenbrand; Charalambos Tsagogiorgas; Christian Patry; Burkhard Tönshoff; Benito Yard; Grietje Beck; Neysan Rafat
Journal:  PLoS One       Date:  2019-06-20       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.